全文获取类型
收费全文 | 3471篇 |
免费 | 286篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 87篇 |
妇产科学 | 60篇 |
基础医学 | 397篇 |
口腔科学 | 79篇 |
临床医学 | 384篇 |
内科学 | 866篇 |
皮肤病学 | 58篇 |
神经病学 | 264篇 |
特种医学 | 189篇 |
外科学 | 378篇 |
综合类 | 87篇 |
一般理论 | 2篇 |
预防医学 | 398篇 |
眼科学 | 25篇 |
药学 | 176篇 |
中国医学 | 1篇 |
肿瘤学 | 302篇 |
出版年
2021年 | 50篇 |
2020年 | 22篇 |
2019年 | 60篇 |
2018年 | 61篇 |
2017年 | 45篇 |
2016年 | 57篇 |
2015年 | 30篇 |
2014年 | 73篇 |
2013年 | 127篇 |
2012年 | 163篇 |
2011年 | 163篇 |
2010年 | 101篇 |
2009年 | 95篇 |
2008年 | 164篇 |
2007年 | 179篇 |
2006年 | 183篇 |
2005年 | 167篇 |
2004年 | 173篇 |
2003年 | 121篇 |
2002年 | 132篇 |
2001年 | 128篇 |
2000年 | 138篇 |
1999年 | 93篇 |
1998年 | 40篇 |
1997年 | 41篇 |
1996年 | 43篇 |
1995年 | 38篇 |
1994年 | 39篇 |
1993年 | 36篇 |
1992年 | 76篇 |
1991年 | 65篇 |
1990年 | 77篇 |
1989年 | 65篇 |
1988年 | 76篇 |
1987年 | 69篇 |
1986年 | 63篇 |
1985年 | 48篇 |
1984年 | 38篇 |
1983年 | 41篇 |
1982年 | 24篇 |
1981年 | 19篇 |
1979年 | 37篇 |
1978年 | 24篇 |
1977年 | 25篇 |
1976年 | 22篇 |
1975年 | 23篇 |
1973年 | 20篇 |
1972年 | 18篇 |
1971年 | 18篇 |
1969年 | 18篇 |
排序方式: 共有3779条查询结果,搜索用时 31 毫秒
81.
Ruth Hallam-Jones Kevan R. Wylie Judith Osborne-Cribb Christine Harrington Stephen Walters 《Sexual and Relationship Therapy》2013,28(2):113-126
Dyspareunia, caused by vulvodynia, has, like other sexual problems, evolved from being conceptualized as a psychological problem through a period when it became viewed by the medical world as a physical problem. It is now seen as being a combination of psychological and physical factors. However, no research to our knowledge has explored in depth the level of sexual and relationship difficulties of this population. This investigation involved 172 women (85 suffering with vulvodynia and 87 women in a control group with general dermatology conditions) to establish the prevalence of relationship and sexual difficulties, using validated questionnaires, a newly devised symptom checklist and a structured interview. The results demonstrated increased levels of sexual and relationship difficulties within the vulvodynia group that need further exploration. 相似文献
82.
83.
Sedeek Mohamed Sedeek Hamid Rahmatullah Bin Abd Razak Gerard WW Ee Andrew HC Tan 《Singapore medical journal》2014,55(10):511-516
The glenohumeral joint is inherently unstable because the large humeral head articulates with the small shadow glenoid fossa. Traumatic anterior dislocation of the shoulder is a relatively common athletic injury, and the high frequency of recurrent instability in young athletes after shoulder dislocation is discouraging to both the patient and the treating physician. Management of primary traumatic shoulder dislocation remains controversial. Traditionally, treatment involves initial immobilisation for 4–6 weeks, followed by functional rehabilitation. However, in view of the high recurrence rates associated with this traditional approach, there has been an escalating interest in determining whether immediate surgical intervention can lower the rate of recurrent shoulder dislocation, improving the patient’s quality of life. This review article aims to provide an overview of the nature and pathogenesis of first-time primary anterior shoulder dislocations, the widely accepted management modalities, and the efficacy of primary surgical intervention in first-time primary anterior shoulder dislocations. 相似文献
84.
Giugliano RP Roe MT Harrington RA Gibson CM Zeymer U Van de Werf F Baran KW Hobbach HP Woodlief LH Hannan KL Greenberg S Miller J Kitt MM Strony J McCabe CH Braunwald E Califf RM;INTEGRITI Investigators 《Journal of the American College of Cardiology》2003,41(8):1251-1260
OBJECTIVES: The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI). BACKGROUND: Glycoprotein IIb/IIIa inhibitors enhance thrombolysis. The role of combination therapy in clinical practice remains to be established. METHODS: Patients (n = 438) with STEMI <6 h were enrolled. In dose-finding, 189 patients were randomized to different combinations of double-bolus eptifibatide and reduced-dose TNK. In dose-confirmation, 249 patients were randomized 1:1 to eptifibatide 180 microg/kg bolus, 2 microg/kg/min infusion, and 180 microg/kg bolus 10 min later (180/2/180) plus half-dose TNK (0.27 mg/kg) or standard-dose (0.53 mg/kg) TNK monotherapy. All patients received aspirin and unfractionated heparin (60 U/kg bolus; infusion 7 U/kg/h [combination], 12 U/kg/h [monotherapy]). The primary end point was Thrombolysis In Myocardial Infarction (TIMI) grade 3 epicardial flow at 60 min. RESULTS: In dose-finding, TIMI grade 3 flow rates were similar across groups (64% to 68%). Arterial patency was highest for eptifibatide 180/2/180 plus half-dose TNK (96%, p = 0.02 vs. eptifibatide 180/2/90 plus half-dose TNK). In dose-confirmation, this combination, compared with TNK monotherapy, tended to achieve more TIMI 3 flow (59% vs. 49%, p = 0.15), arterial patency (85% vs. 77%, p = 0.17), and ST-segment resolution (median 71% vs. 61%, p = 0.08) but was associated with more major hemorrhage (7.6% vs. 2.5%, p = 0.14) and transfusions (13.4% vs. 4.2%, p = 0.02). Intracranial hemorrhage occurred in 1.0%, 0.6%, and 1.7% of patients treated with any combination, eptifibatide 180/2/180 and half-dose TNK, and TNK monotherapy, respectively. CONCLUSIONS: Double-bolus eptifibatide (180/2/180) plus half-dose TNK tended to improve angiographic flow and ST-segment resolution compared with TNK monotherapy but was associated with more transfusions and non-cerebral bleeding. Further study is needed before this combination can be recommended for general use. 相似文献
85.
Melloni C Alexander KP Milford-Beland S Newby LK Szczech LA Pollack CV Kirk JD Christenson RH Harrington RA Gibler WB Ohman EM Peterson ED Roe MT;Crusade Investigators 《Clinical cardiology》2008,31(3):125-129
BACKGROUND: The prognostic value of cardiac troponins (cTn) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS) and chronic kidney disease (CKD) is debated. HYPOTHESIS: We tested the performance of cTnI and cTnT for risk stratification in patients with CKD and evaluated the prognostic significance of cTnI and cTnT elevations by their magnitude across the range of CKD severity. METHODS: We examined correlations among cTn elevation, CKD, and in-hospital mortality in 31,586 high-risk patients with NSTE ACS included in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines initiative (CRUSADE). Cardiac tropinins I and T levels were categorized as ratios of each site's upper limit of normal (ULN) for myocardial necrosis: normal (cTn ratio < or =1 x ULN), mild (cTn ratio > 1-3 x ULN), and major (cTn ratio > 3 x ULN) elevation. Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in Renal Disease equation. Stages of CKD were categorized as normal to mild (eGFR > 60 mL/min), moderate (eGFR 30-60 mL/min), or severe (eGFR < 30 mL/min). RESULTS: Mortality increased more steeply across CKD stages (2.0%-12.9%) than across cTn ratio categories (2.7%-5.4%). In normal or mild CKD, mortality was low regardless of cTn elevations. In moderate CKD, mortality increased incrementally with cTnI (3.3% versus 5.4% versus 7.4%) and cTnT (3.7% versus 5.3% versus 7.3%) elevation. Among severe CKD patients, only major cTn elevations further distinguished risk (cTnI: 10.1% versus 9.7% versus 14.6%; cTnT: 7.0% versus 5.7% versus 14.0%). CONCLUSIONS: In patients with CKD, cTnI and cTnT perform equally in differentiating short-term prognosis following NSTE ACS; however, the prognostic impact of cTn is dependent upon the degree of CKD severity. 相似文献
86.
Tan Huay-Cheem Harrington Robert A. Tcheng James E. 《Journal of thrombosis and thrombolysis》1997,4(3-4):431-439
Platelets have been shown to play an important role in the pathogenesis of atherosclerosis, acute coronary syndromes, and ischemic complications after percutaneous coronary intervention. Fibrinogen binding via platelet surface glycoprotein (GP) IIb/IIIa receptors constitutes the "final pathway" in platelet aggregation leading to thrombus formation. The GP IIb/IIIa receptor inhibitors, a new class of antiplatelet agents that have emerged in recent years, show great promise in reducing complications of coronary angioplasty and acute coronary syndromes. This review will examine the biology of platelet GP IIb/IIIa receptors, the various classes of GP IIb/IIIa receptor antagonists, the results of the latest clinical trials, and their implications in current clinical practice. 相似文献
87.
Giugliano RP Sabatine MS Gibson CM Roe MT Harrington RA Murphy SA Morrow DA Antman EM Braunwald E 《The American journal of cardiology》2004,93(11):1362-7, A5-6
The restoration of epicardial and myocardial flow remains the primary goal of reperfusion therapy in patients with ST-segment elevation myocardial infarction, but the optimal method to assess this goal has not been defined. Thrombolysis In Myocardial Infarction flow grade (TFG), myocardial perfusion grade (MPG), and ST-segment resolution (STRes) were combined to formulate a new measure of successful reperfusion in 649 patients who received pharmacologic reperfusion therapy in 3 recent phase II clinical trials of ST-segment elevation myocardial infarction. Coronary angiograms and electrocardiograms were analyzed at 60 minutes (before any intervention) after the initiation of reperfusion therapy. The complete restoration of perfusion, or the "trifecta," defined as the presence of TFG 3, MPG 3, and complete (> or =70%) STRes, occurred in 117 patients (18%). The achievement of this trifecta was associated with low rates of 30-day mortality (0% vs 3.9%, p = 0.02), congestive heart failure (CHF) (0.9% vs 7.1%, p = 0.01), and the combination of death or CHF (0.9% vs 10.7%, p = 0.001). When the results were stratified with respect to subsequent percutaneous coronary intervention (PCI) from 60 to 120 minutes, attainment of the trifecta at 60 minutes remained a strong predictor of better clinical outcomes, particularly in those patients who underwent early PCI. The achievement of TFG 3, MPG 3, and complete STRes at 60 minutes after fibrinolytic therapy and before PCI occurred in only 18% of patients but was associated with very low rates of death and CHF at 30 days. This new end point is proposed to evaluate the success of reperfusion therapy in patients who undergo early angiography. 相似文献
88.
Zampieron A Harrington M Elseviers M Lindley E De Vos JY Visser R 《EDTNA/ERCA journal (English ed.)》2004,30(2):59-61
The Research Board (RB) of EDTNA/ERCA is a multidisciplinary group, established by the participation of renal care centres all around Europe. The RB also works with the association's Special Interest Groups (SIGs) on developing guidelines for implementing safe renal clinical practice. It is composed of six permanent members, with co-opted experts from specific fields. This article describes how the RB works and the projects implemented since 1996. 相似文献
89.
Zampieron A Jayasekera H Elseviers M Lindley E De Vos JY Visser R Harrington M 《EDTNA/ERCA journal (English ed.)》2004,30(2):84-90
Haemodialysis patients are known to be at risk of infection of Hepatitis C Virus (HCV) through nosocomial spread. This paper presents the first part of a study on epidemiology and management of HCV, in a haemodialysis population, conducted by the EDTNA/ERCA Research Board. Data on HCV management and infection control procedures was collected from 136 European centres using an electronic questionnaire. The study identifies a number of possible risk factors for transmission of the virus: failing to disinfect devices between patients, sharing of single-use vials to prepare drugs or infusions for different patients, inadequate sterilisation or cleaning of machines between dialysis sessions, unsatisfactory environmental cleaning and distance less than one metre between chairs. 相似文献
90.
Evdokia Kalaitzidis Ann Harrington 《Collegian (Royal College of Nursing, Australia)》2018,25(5):509-515